10/3/22 08:47  | 9/30/22  | IGXT | Health | Drug | Pharmaceutical Preparations | Zerbe Horst G | A8 | DO | CEO | P | 2 | 0.1251 | 0 | 19 | 0 | 8,845 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/3/22 08:12  | 9/29/22  | IGXT | Health | Drug | Pharmaceutical Preparations | Godin Andre | A8 | O | P,CFO | P | 1 | 0.1240 | 0 | 5 | 2 | 308 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/29/22 08:01  | 9/27/22  | IGXT | Health | Drug | Pharmaceutical Preparations | Godin Andre | A8 | O | P,CFO | P.m | 1 | 0.1346 | 0 | 10 | 3 | 303 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/28/22 08:00  | 9/26/22  | IGXT | Health | Drug | Pharmaceutical Preparations | Kenny Tommy | A8 | O | VP IP Le | P | 3 | 0.1350 | 0 | 19 | 16 | 139 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/26/22 08:27  | 9/22/22  | IGXT | Health | Drug | Pharmaceutical Preparations | Kenny Tommy | A8 | O | VP IP Le | P.m | 5 | 0.1457 | 0 | 34 | 17 | 229 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/22/22 16:15  | 9/21/22  | IGXT | Health | Drug | Pharmaceutical Preparations | Godin Andre | A8 | O | P,CFO | P | 3 | 0.1340 | 0 | 20 | 7 | 293 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/22/22 09:26  | 9/21/22  | IGXT | Health | Drug | Pharmaceutical Preparations | Matzen Dana | A8 | O | VP BD,Co | P | 3 | 0.1380 | 0 | 25 | 42 | 85 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/31/22 16:00  | 3/30/22  | IGXT | Health | Drug | Pharmaceutical Preparations | Matzen Dana | A8 | O | VP BD,Co | P | 7 | 0.2650 | 0 | 25 | 71 | 60 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/11/21 15:25  | 6/8/21  | IGXT | Health | Drug | Pharmaceutical Preparations | Matzen Dana | A8 | O | VP BD,Co | P | 5 | 0.4800 | 0 | 10 | 40 | 35 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/13/21 10:57  | 4/13/21  | IGXT | Health | Drug | Pharmaceutical Preparations | Matzen Dana | A8 | O | VP BD,Co | P | 12 | 0.4890 | 0 | 25 | New | 25 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/9/21 11:18  | 4/7/21  | IGXT | Health | Drug | Pharmaceutical Preparations | Kenny Tommy | A8 | O | VP IP Le | P | 9 | 0.4455 | 0 | 20 | 30 | 86 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/7/21 16:03  | 4/7/21  | IGXT | Health | Drug | Pharmaceutical Preparations | Godin Andre | A8 | O | P,CFO | P | 9 | 0.4400 | 0 | 20 | 11 | 200 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/6/21 15:52  | 3/30/21  | IGXT | Health | Drug | Pharmaceutical Preparations | Boudreau Bernard | A5 | D |  | P.m | 11 | 0.4325 | 0 | 25 | 14 | 202 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/7/21 09:25  | 1/6/21  | IGXT | Health | Drug | Pharmaceutical Preparations | Zerbe Ingrid | A8 | O | Corporat | S | 0 | 0.2440 | 0 | -1 | 0 | 10,636 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/8/20 15:34  | 4/7/20  | IGXT | Health | Drug | Pharmaceutical Preparations | Godin Andre | A8 | O | P,CFO | P | 2 | 0.1530 | 0 | 15 | 9 | 178 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/23/19 09:45  | 8/22/19  | IGXT | Health | Drug | Pharmaceutical Preparations | Godin Andre | A8 | O | P,CFO | P | 4 | 0.4290 | 0 | 10 | 7 | 162 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/15/19 09:29  | 4/12/19  | IGXT | Health | Drug | Pharmaceutical Preparations | Godin Andre | A8 | O | EVP,CFO | P | 7 | 0.4950 | 0 | 15 | 11 | 152 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/26/18 16:00  | 12/20/18  | IGXT | Health | Drug | Pharmaceutical Preparations | Godin Andre | A8 | O | EVP,CFO | P.d | 5 | 0.5040 | 0 | 10 | 8 | 137 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/11/18 10:44  | 12/10/18  | IGXT | Health | Drug | Pharmaceutical Preparations | Godin Andre | A8 | O | EVP,CFO | P | 6 | 0.5830 | 0 | 10 | 9 | 127 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/13/18 10:31  | 7/12/18  | IGXT | Health | Drug | Pharmaceutical Preparations | Boudreau Bernard | A5 | D |  | M.d | 20 | 0.5800 | 0 | 35 | 30 | 150 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/13/18 10:06  | 7/12/18  | IGXT | Health | Drug | Pharmaceutical Preparations | Godin Andre | A8 | O | EVP,CFO | P | 12 | 0.7550 | 0 | 16 | 15 | 116 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/10/18 16:05  | 5/8/18  | IGXT | Health | Drug | Pharmaceutical Preparations | Godin Andre | A8 | O | EVP,CFO | P.d | 10 | 0.6300 | 0 | 16 | 19 | 100 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/26/17 16:30  | 6/13/17  | IGXT | Health | Drug | Pharmaceutical Preparations | Paiement Nadine | A8 | O | VP R,D | M.d | 5 | 0.5100 | 0 | 10 | 20 | 60 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/30/16 15:42  | 11/28/16  | IGXT | Health | Drug | Pharmaceutical Preparations | Boudreau Bernard | A5 | D |  | M.d | 22 | 0.5400 | 0 | 40 | 83 | 88 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/30/16 15:42  | 11/30/16  | IGXT | Health | Drug | Pharmaceutical Preparations | Boudreau Bernard | A5 | D |  | S.d | -19 | 0.7503 | 0 | -25 | -22 | 88 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/11/16 13:54  | 10/7/16  | IGXT | Health | Drug | Pharmaceutical Preparations | Durham John Edward | A8 | O | VP Manuf | P | 2 | 0.7600 | 0 | 3 | 30 | 13 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/23/16 09:24  | 9/21/16  | IGXT | Health | Drug | Pharmaceutical Preparations | Durham John Edward | A8 | O | VP Manuf | P | 8 | 0.8329 | 0 | 10 | New | 10 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/15/16 14:55  | 9/14/16  | IGXT | Health | Drug | Pharmaceutical Preparations | Godin Andre | A8 | O | EVP,CFO | P | 14 | 0.7188 | 0 | 20 | 31 | 85 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/28/16 13:54  | 1/22/16  | IGXT | Health | Drug | Pharmaceutical Preparations | Bechard Robert J. | A8 | O | VP Corpo | P | 5 | 0.4978 | 0 | 10 | New | 10 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/25/16 16:01  | 1/20/16  | IGXT | Health | Drug | Pharmaceutical Preparations | Boudreau Bernard | A5 | D |  | P.m | 32 | 0.4900 | 0 | 65 | 186 | 100 | M |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/22/16 15:50  | 1/20/16  | IGXT | Health | Drug | Pharmaceutical Preparations | Godin Andre | A8 | O | EVP + CF | P | 8 | 0.4000 | 0 | 20 | 45 | 65 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/31/15 15:54  | 12/30/15  | IGXT | Health | Drug | Pharmaceutical Preparations | Godin Andre | A8 | O | EVP,CFO | P | 5 | 0.5180 | 0 | 10 | 27 | 45 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/24/15 09:57  | 12/23/15  | IGXT | Health | Drug | Pharmaceutical Preparations | Godin Andre | A8 | O | EVP + CF | P | 8 | 0.5107 | 0 | 15 | 78 | 35 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/23/15 10:20  | 12/21/15  | IGXT | Health | Drug | Pharmaceutical Preparations | Godin Andre | A8 | O | EVP + CF | P.m | 10 | 0.5032 | 0 | 20 | New | 20 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/26/15 16:03  | 8/25/15  | IGXT | Health | Drug | Pharmaceutical Preparations | Zerbe Horst G | A8 | DO | CEO | S | -18 | 0.5000 | 0 | -37 | -1 | 4,588 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/26/15 16:02  | 8/25/15  | IGXT | Health | Drug | Pharmaceutical Preparations | Zerbe Ingrid | A8 | O | Corporat | S | -82 | 0.5000 | 0 | -163 | -3 | 5,456 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/4/15 13:36  | 7/31/15  | IGXT | Health | Drug | Pharmaceutical Preparations | Marinucci John | A6 | D |  | M.d | 28 | 0.3700 | 0 | 75 | New | 75 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/21/15 16:36  | 5/17/15  | IGXT | Health | Drug | Pharmaceutical Preparations | Melchers Bernd Josef | V8 | D |  | M.d | 34 | 0.4500 | 0 | 75 | 167 | 120 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/20/15 16:03  | 4/16/15  | IGXT | Health | Drug | Pharmaceutical Preparations | Zerbe Ingrid | A8 | O | Corporat | S.m | -44 | 0.6617 | 0 | -67 | -1 | 5,619 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/20/15 16:03  | 4/16/15  | IGXT | Health | Drug | Pharmaceutical Preparations | Zerbe Horst G | A8 | DO | CEO | S.m | -40 | 0.6630 | 0 | -60 | -1 | 4,625 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/10/15 09:58  | 4/7/15  | IGXT | Health | Drug | Pharmaceutical Preparations | Zerbe Ingrid | A8 | O | Corporat | S | -13 | 0.6400 | 0 | -20 | 0 | 5,686 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/3/14 15:03  | 1/29/14  | IGXT | Health | Drug | Pharmaceutical Preparations | Zerbe Ingrid | A8 | O | Corporat | S.m | -231 | 0.9244 | 0 | -250 | -4 | 5,706 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/3/14 15:02  | 1/29/14  | IGXT | Health | Drug | Pharmaceutical Preparations | Zerbe Horst G | A8 | D |  | S.m | -231 | 0.9244 | 0 | -250 | -5 | 4,685 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/13/12 11:59  | 11/9/12  | IGXT | Health | Drug | Pharmaceutical Preparations | Blumont Capital Corp | A6 | T |  | P | 47 | 0.6720 | 0 | 70 | 1 | 6,213 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/12/12 14:12  | 10/10/12  | IGXT | Health | Drug | Pharmaceutical Preparations | Blumont Capital Corp | A6 | T |  | P.m | 136 | 0.6645 | 0 | 205 | 3 | 6,143 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/20/12 16:10  | 9/19/12  | IGXT | Health | Drug | Pharmaceutical Preparations | Blumont Capital Corp | A6 | T |  | P | 87 | 0.6034 | 0 | 145 | 3 | 5,938 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/10/12 14:58  | 9/7/12  | IGXT | Health | Drug | Pharmaceutical Preparations | Blumont Capital Corp | A6 | T |  | P | 55 | 0.5969 | 0 | 92 | 2 | 5,793 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/16/12 12:31  | 8/15/12  | IGXT | Health | Drug | Pharmaceutical Preparations | Blumont Capital Corp | A6 | T |  | P | 96 | 0.5646 | 0 | 170 | 3 | 5,701 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/31/12 17:54  | 7/27/12  | IGXT | Health | Drug | Pharmaceutical Preparations | Blumont Capital Corp | A6 | T |  | P.m | 99 | 0.5836 | 0 | 170 | 3 | 5,531 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/12/12 10:22  | 7/10/12  | IGXT | Health | Drug | Pharmaceutical Preparations | Blumont Capital Corp | A6 | T |  | P.m | 45 | 0.5298 | 0 | 84 | 2 | 5,361 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/19/12 12:53  | 6/18/12  | IGXT | Health | Drug | Pharmaceutical Preparations | Blumont Capital Corp | A6 | T |  | P | 43 | 0.5377 | 0 | 80 | 2 | 5,276 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/15/12 14:15  | 5/10/12  | IGXT | Health | Drug | Pharmaceutical Preparations | Blumont Capital Corp | A6 | T |  | P | 63 | 0.5044 | 0 | 125 | 2 | 5,196 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/1/12 16:08  | 4/30/12  | IGXT | Health | Drug | Pharmaceutical Preparations | Blumont Capital Corp | A6 | T |  | P | 38 | 0.4774 | 0 | 80 | 2 | 5,071 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/13/12 12:07  | 2/28/11  | IGXT | Health | Drug | Pharmaceutical Preparations | Blumont Capital Corp | A6 | T |  | P.dm | 181 | 0.5319 | 0 | 340 | 7 | 4,991 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/13/12 12:07  | 2/28/11  | IGXT | Health | Drug | Pharmaceutical Preparations | Blumont Capital Corp | A6 | T |  | S.dm | -91 | 0.5270 | 0 | -173 | -3 | 4,991 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/24/12 14:52  | 2/14/12  | IGXT | Health | Drug | Pharmaceutical Preparations | Blumont Capital Corp | A6 | T |  | P | 18 | 0.5941 | 0 | 30 | 1 | 4,854 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/10/11 16:36  | 11/9/11  | IGXT | Health | Drug | Pharmaceutical Preparations | Zerbe Ingrid | A8 | OT | Corporat | M.d | 92 | 0.4100 | 0 | 225 | 4 | 5,956 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/10/11 16:36  | 11/9/11  | IGXT | Health | Drug | Pharmaceutical Preparations | Zerbe Horst G | A8 | OT | CEO | M.d | 92 | 0.4100 | 0 | 225 | 5 | 4,935 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/1/11 11:51  | 7/26/11  | IGXT | Health | Drug | Pharmaceutical Preparations | Melchers Bernd Josef | 2M | D |  | P.d | 16 | 0.8100 | 0 | 20 | 80 | 45 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/19/11 17:25  | 4/14/11  | IGXT | Health | Drug | Pharmaceutical Preparations | Melchers Bernd Josef | 2M | D |  | P.d | 15 | 0.5900 | 0 | 25 | New | 25 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/28/09 12:59  | 7/23/09  | IGXT | Health | Drug | Pharmaceutical Preparations | Cohen Joel Charles | A8 | H | Former D | S | -121 | 0.5500 | 0 | -220 | -40 | 330 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/5/09 16:08  | 5/12/09  | IGXT | Health | Drug | Pharmaceutical Preparations | Zerbe Ingrid | A8 | OT | Secretar | P.d | 4 | 0.0041 | 0 | 1,022 | 22 | 5,731 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/2/09 19:48  | 5/12/09  | IGXT | Health | Drug | Pharmaceutical Preparations | Cohen Joel Charles | A8 | D |  | S.d | -4 | 0.0041 | 0 | -1,022 | -65 | 550 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/2/09 17:09  | 6/29/09  | IGXT | Health | Drug | Pharmaceutical Preparations | Northern Rivers Capital Management Inc. | A6 | T |  | P | 5 | 0.4200 | 0 | 12 | 0 | 2,329 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/2/09 17:03  | 3/31/09  | IGXT | Health | Drug | Pharmaceutical Preparations | Northern Rivers Capital Management Inc. | A6 | T |  | P | 0 | 0.3600 | 0 | 1 | 0 | 2,318 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/2/09 16:46  | 2/26/09  | IGXT | Health | Drug | Pharmaceutical Preparations | Northern Rivers Capital Management Inc. | A6 | T |  | P | 2 | 0.4900 | 0 | 5 | 0 | 2,317 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/13/09 16:40  | 12/31/08  | IGXT | Health | Drug | Pharmaceutical Preparations | Northern Rivers Capital Management Inc. | A6 | T |  | P.m | 36 | 0.6350 | 0 | 56 | 2 | 2,312 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/13/09 16:40  | 1/30/09  | IGXT | Health | Drug | Pharmaceutical Preparations | Northern Rivers Capital Management Inc. | A6 | T |  | S | 0 | 0.6500 | 0 | -1 | 0 | 2,312 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/26/08 17:07  | 8/20/08  | IGXT | Health | Drug | Pharmaceutical Preparations | Boudreau Bernard | A5 | D |  | M.d | 25 | 0.7000 | 0 | 35 | New | 35 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/14/06 12:11  | 11/9/06  | IGXT | Health | Drug | Pharmaceutical Preparations | Zerbe Horst G | A8 | DOT | CEO,P | M.d | 92 | 0.4100 | 0 | 225 | 5 | 4,935 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/14/06 11:26  | 11/9/06  | IGXT | Health | Drug | Pharmaceutical Preparations | Zerbe Ingrid | A8 | OT | Secretar | M.d | 92 | 0.4100 | 0 | 225 | 5 | 4,935 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  |